Muscle Spasm Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 35
Mycobacterium Tuberculosis Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 267
Human Cytomegalovirus Glycoprotein H (gH) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molec...
Published: May 2022 - Pages: 35
Myotonic Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 74
Neisseria Gonorrhoeae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 65
Neuroendocrine Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 173
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Drugs in Development by Stages, Target, MoA, RoA...
Published: May 2022 - Pages: 102
Nonmelanomatous Skin Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 116
Non-Small Cell Lung Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 112
Ocular Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 164
Liver X Receptor (LXR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Pl...
Published: May 2022 - Pages: 42
Ocular Pain (Eye Pain) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 55
Open-Angle Glaucoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 81
Opioid Induced Side Effects Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 48
Oropharyngeal Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 35
Pancreatic Ductal Adenocarcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 254
Neuronal Acetylcholine Receptor Subunit Alpha 3 (CHRNA3) Drugs in Development by Therapy Areas and Indications, Stages, ...
Published: May 2022 - Pages: 35
Pancreatic Endocrine Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 37
Pandemic Influenza Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 81
Papillary Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 64
